Netherlands· NL-a68d08d98465

Erlotinib Amarox 150 mg filmomhulde tabletten

A erlotinib product containing erlotinibhydrochloride, registered in Netherlands by Amarox Pharma B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC L01EB02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about erlotinibhydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Erlotinib is registered in 14 of 19 countries.

Countries holding a registration under ATC L01EB02 (erlotinib), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search erlotinib products by name

Erlotinib · ATC L01EB02

14 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of erlotinib costs, country by country.

Normalised to the WHO defined daily dose (0.15 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Erlotinib · price per daily dose (0.15 g)

USD · FX 28 Sept 2026

CH Switzerland$102.78

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ERLOTINIBHYDROCHLORIDE
Manufacturer: Amarox Pharma B.V.
Country: Netherlands (NL)
ATC code: L01EB02
ATC class: Erlotinib
Defined daily dose: 0.15 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
119579

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

355 interactions on record for erlotinib.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check erlotinib against other medicines How interaction checks work

Erlotinib · interactions on record

355 records

14 severe
192 moderate
2 minor
147 info

Most severe, free to view

OmeprazoleA02BC01severe
PantoprazoleA02BC02severe
LansoprazoleA02BC03severe
RabeprazoleA02BC04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Erlotinib in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All erlotinib products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Belgium · Erlotinib Sandoz
Bulgaria · Ерлотиниб Актавис, Ерлотиниб Крка
Cyprus · Erlotinib Remedica
Czechia · Erlotinib Krka, Erlotinib Teva
Germany · Erlotev, Erlotinib Axiromed
Denmark · Erlotinib "stada", Erlotinib Krka
Estonia · Erlotinib Viatris
Spain · Erlotinib Sandoz, Erlotinib Tarbis
Finland · Erlotinib Krka, Erlotinib Stada
France · Erlotinib Biogaran, Erlotinib Eg
United Kingdom (Northern Ireland) · Erlotinib Amarox, Erlotinib Glenmark
Greece · Erlotinib Faran, Erlotinib Teva
Croatia · Erlotinib Alpha-Medical, Erlotinib Krka
Hungary · Erlotinib Actavis, Erlotinib Krka
Iceland · Erlotinib Krka, Erlotinib Teva
Italy · Erlotinib Mylan, Erlotinib Sandoz
Liechtenstein · Tarceva
Lithuania · Erlotinib Viatris, Varlota
Latvia · Erlotinib Sandoz, Erlotinib Viatris
Norway · Erlotinib Krka, Tarceva
Poland · Erlotinib Zentiva
Portugal · Erlotinib Mylan, Erlotinib Qritou
Romania · Erlotinib Krka, Erlotinib Viatris
Sweden · Erlotinib Krka, Erlotinib Medical Valley
Slovenia · Erlotinib Krka, Erlotinib Teva
Slovakia · Erlotinib Sandoz, Erlotinib Stada

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/650cc779-58ca-4988-9ccd-5a39ba118499
GET /v1/drugs/650cc779-58ca-4988-9ccd-5a39ba118499?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h119579_smpc.pdf",
  "strength": null,
  "atc_label": "Erlotinib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg119579",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROLOSE (E 463)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "LACTOSE 1-WATER",
    "MACROGOL 400",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMLAURILSULFAAT",
    "NATRIUMZETMEELGLYCOLAAT",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "ERLOTINIBHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h119579.pdf",
  "authorised_at": "2018/03/26",
  "procedure_number": "NL/H/3814/003",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "119579",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about erlotinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console